ValsartanFollowing recent patterns of voluntary prescription drug recalls related to undeclared or undetected carcinogen ingredients found in several blood pressure and heart disease treatment medications, the FDA has issued a new voluntary prescription drug recall for several medications containing N-nitrosodimethylamine as a sub ingredient of valsartan.

While valsartan has thus far been identified as a “probable”, it should be noted that legal use and prescription of drugs containing valsartan has been banned in over 20 countries as of July 13th 2018.

The current Food and Drug Administration does not ban all prescription medications sold within the United States but instead recalls and prohibits further prescribing or sales of specific medications containing valsartan. Drug manufacturers included in the U.S. recall include: Solco Healthcare, Major Pharmaceuticals, and Teva Pharmaceuticals Industries Ltd. with the specific addition of valsartan/hydrochlorothiazide (HCTZ) manufactured or compounded by Solco Healthcare and Teva Pharmaceuticals Industries Ltd.


Do I have a lawsuit will continue to monitor this prescription drug recall and as always update you as more information becomes available.

Discuss this article in the forums (0 replies).